GLP-1 guide · sources linked
Muscle loss on GLP-1 medicines: what the lean mass research shows
When you lose weight, some of it is lean mass, not only fat. Body-scan studies from the semaglutide and tirzepatide trials show how that split looked. Here is what the research shows and what experts commonly suggest to protect muscle.
By Jacob Teague · Updated October 20, 2026 · Not medical advice
What the research shows
Both the Wegovy and Zepbound labels state that the medicine lowers body weight with greater fat mass loss than lean mass loss.1, 2
Some trial participants had DXA body scans, which split body weight into fat and lean mass.
- STEP 1 (semaglutide): total fat mass fell by 19.3% and lean body mass by 9.7%. A joint nutrition advisory from four obesity and nutrition societies notes that about 38% of the average weight lost in STEP 1 was lean mass, which includes muscle and other non-fat tissue.3, 4
- SURMOUNT-1 (tirzepatide): fat mass fell by 33.9% and lean mass by 10.9%. About 75% of the weight lost was fat.3
- Strength and function: a 2026 review found no consistent decline in strength or physical function with these medicines. It also noted that no randomized study has shown a meaningful gain in strength.3
Why it happens
Rapid weight loss from any cause, not only GLP-1 medicines, often includes both fat and muscle. The joint advisory says how much lean mass is lost depends on how big the calorie cut is, how fast the weight comes off, and whether you do strength training.4
Appetite matters too. The advisory says eating less protein because of a smaller appetite may add to muscle loss, especially with older age, menopause, low activity, or no strength training. Cleveland Clinic suggests eating protein first at meals for this reason.4, 5
Lean mass is not the same as muscle. It also includes other non-fat tissue. The advisory estimates that muscle is about half of lean mass, so the 38% lean-mass share in STEP 1 corresponds to roughly 20% of the weight lost being muscle.4
What people commonly do
Expert groups mostly agree on two habits: strength training and adequate protein. The joint advisory stresses that extra protein on its own is unlikely to preserve muscle without strength training.4
- Structured strength training. The joint advisory recommends it at least three times a week, along with at least 150 minutes a week of moderate aerobic activity.4
- Start gently if you're new to exercise. Cleveland Clinic suggests 10 to 15 minutes of light activity a day at first, then building up.5
- Prioritize protein at each meal. Cleveland Clinic lists chicken, fish, eggs, Greek yogurt, cottage cheese, and legumes as sources, and suggests working with a dietitian to set a target.5
- Stay hydrated, especially around exercise.5
- Ask about checking progress. The 2026 review suggests periodic checks of body composition and physical performance, especially for people at higher risk, such as older adults.3
When to contact a clinician or get urgent care
Let your clinician know if you're starting a new exercise routine, or if you notice you're getting weaker or struggling with everyday tasks. Cleveland Clinic says to stop exercising and contact your healthcare provider if you feel dizzy, nauseated, or short of breath, as these can signal low blood sugar.5
The FDA medication guides list these warning signs too:
- If you also use insulin or a sulfonylurea: shakiness, sweating, dizziness, confusion or drowsiness, a fast heartbeat, or blurred vision. These can be signs of low blood sugar.1, 2
- Nausea, vomiting, or diarrhea that does not go away, or signs of dehydration such as dark, strong-smelling urine, peeing less than usual, or dizziness when you stand that does not pass. The labels say fluid loss from these symptoms can lead to kidney problems.1, 6
- Severe pain in your stomach area that will not go away, with or without vomiting. The pain may spread to your back. The FDA medication guides list this as a possible sign of pancreatitis (inflammation of the pancreas) and say to call your healthcare provider right away.1, 2, 7
- Pain in your upper stomach, yellowing of your skin or the whites of your eyes, fever, or clay-colored stools. These can be signs of gallbladder problems, including gallstones.1, 2
- Swelling of your face, lips, tongue, or throat, problems breathing or swallowing, a severe rash or itching, fainting or feeling dizzy, or a very rapid heartbeat. These are signs of a serious allergic reaction. The medication guides say to get medical help right away.1, 2
Tracking it
Protein, training, and weight change are easier to manage when you can see them side by side over weeks rather than day to day.
Peptide Vault lets you log injections and use daily check-ins for weight, protein, water, and sleep, plus notes such as workouts or how strong you felt. You can export a PDF doctor sheet to review with your clinician or dietitian. The app is for tracking. It does not preserve muscle or change your results.
Keep a record you can show your clinician
Peptide Vault logs each dose as prescribed, how you felt and any side effects, privately on your iPhone.
Questions
Do you lose muscle on semaglutide?
Some lean mass loss happens with any weight loss. In the STEP 1 body-scan study, fat mass fell by 19.3% and lean mass by 9.7%. The Wegovy label says weight loss involved more fat loss than lean mass loss.
Is muscle loss worse on tirzepatide or semaglutide?
The trials were separate, so they can't be compared directly. In SURMOUNT-1, about 75% of the weight lost on tirzepatide was fat. In STEP 1, about 38% of the weight lost on semaglutide was lean mass.
How can I keep muscle on a GLP-1?
Expert groups suggest regular strength training plus adequate protein. A joint advisory from four obesity and nutrition societies stresses that protein alone is unlikely to be enough without strength training.
Does losing lean mass make you weaker?
A 2026 review found no consistent decline in strength or physical function with these medicines, but noted this hasn't been well studied in randomized trials.
Sources
- Wegovy (semaglutide) prescribing information and Medication Guide, DailyMed / U.S. National Library of Medicine
- Zepbound (tirzepatide) prescribing information and Medication Guide, DailyMed / U.S. National Library of Medicine
- De Girolamo G, et al. Muscle health in the modern era of incretin-based therapies. European Journal of Clinical Investigation. 2026
- Mozaffarian D, et al. Nutritional priorities to support GLP-1 therapy for obesity: a joint Advisory (ACLM, ASN, OMA, TOS). Obesity. 2025
- Taking GLP-1s? Make Sure You Exercise, Cleveland Clinic
- Dehydration, NHS
- Acute pancreatitis, NHS
More GLP-1 guides
Educational summary from the sources above, written by Jacob Teague and not reviewed by a clinician. It is not medical advice and does not recommend medicines, doses or changes to treatment. If you have symptoms that worry you, contact the clinician who prescribed your medication or seek urgent care.